Breast Cancer

Hope? Several years out, a breast cancer and melanoma survivor contemplates what comforted her and could have comforted at the time of diagnosis and early in her treatment.

Am I alone in wanting to reassure everyone I meet?

The designation, which will expedite the development and review of sacituzumab govitecan in TNBC, is based on a phase 2 trial in which the therapy induced a response rate of 31 percent in heavily pretreated patients with metastatic TNBC.

Learning to accept my body after a double mastectomy.

These data were presented in mid-December 2015.

Following doctors orders is what we're supposed to do, but sometimes it's a personal choice.

Exercise, protein, belief and visualization are my not-so-secret weapons in my life with metastatic breast cancer.

A male breast cancer survivor shares his humorous twist to health and healing.

A cancer survivor wonders if chemicals contributed to her breast cancer or melanoma.

In an interview with CURE, Anees B. Chagpar, from The Breast Center at Smilow Cancer Hospital at Yale-New Haven, shares her thoughts on the final guidelines and how they change the focus of screening.

Doing a little reflection about where I've been and how far I've come is just as important as making resolutions.